Irritable bowel syndrome

550 mg PO TID for 14 days

1 mg PO BID

50 mg PO BID

Tenapanor

Rifaximin

Alosetron

diarrhea

flatulence

dizziness

hyperkalemia

abdominal distension

Treatment of irritable bowel syndrome in female adults (severe, diarrhea-predominant)

Tenapanor hydrochloride PO

Rifaximin PO

Alosetron hydrochloride PO

The manufacturer makes no recommendation regarding use during pregnancy.
Malformative risk with use of this drug in pregnant women is unlikely.
This drug is minimally absorbed after oral administration (i.e., less than 0.5 ng/mL).

American College of Gastroenterology

ACG Clinical Guideline: Management of Irritable Bowel Syndrome.

Tenapanor

Table of contents